[Form 4] Deluxe Corporation Insider Trading Activity

Rhea-AI Filing Summary

Deluxe Corporation (DLX) director Michelle T. Collins was granted 6,279 restricted stock units (RSUs). The Form 4 reports a grant on 08/20/2025 of 6,279 RSUs with a $0 conversion/exercise price that vest one year from grant, on 08/20/2026, and correspond to 6,279 shares of common stock. Following the reported transaction, Ms. Collins beneficially owns 6,279 shares, held directly. The filing is signed by an attorney-in-fact on 08/22/2025.

Insights

Financial Analyst

TL;DR: Routine director equity grant; modest share amount, standard one-year vesting.

The Form 4 documents a non-derivative grant of 6,279 restricted stock units to a company director, executed 08/20/2025 and vesting 08/20/2026. The grant carries no exercise price and converts to 6,279 common shares upon vesting, and is reported as direct beneficial ownership. This is a typical equity compensation event for board members and, given the size and single-year vesting disclosed here, appears routine rather than material to corporate valuation.

Corporate Governance Expert

TL;DR: Standard governance disclosure; aligns director compensation with shareholder interests.

The filing provides clear disclosure of a director award: 6,279 RSUs granted to Michelle T. Collins on 08/20/2025, vesting on 08/20/2026, reported as direct ownership. The disclosure meets Section 16 reporting requirements and shows customary use of equity awards for director compensation. No additional information on vesting conditions beyond the one-year vest date is provided in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Collins Michelle T

(Last) (First) (Middle)

801 S. MARQUETTE AVE.

(Street)

MINNEAPOLIS MN 55402

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DELUXE CORP [ DLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0	08/20/2025		A		6,279		08/20/2026(1)	08/20/2026	Common Stock	6,279	$0	6,279	D

Explanation of Responses:

1. Restricted stock units vest one year from the date of grant.

Remarks:

	/s/ Kortney Q. Nordrum, Attorney in Fact	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Michelle T. Collins report on Form 4 for DLX?

The Form 4 reports a grant of 6,279 restricted stock units (RSUs) to Michelle T. Collins on 08/20/2025.

When do the RSUs granted to the DLX director vest?

The RSUs vest one year from the date of grant, on 08/20/2026, per the filing explanation.

How many shares will the 6,279 RSUs convert into for DLX?

The filing shows the RSUs correspond to 6,279 shares of common stock upon vesting and are reported as direct beneficial ownership.

Was there a price paid for the RSUs reported on the Form 4?

No exercise or conversion price is indicated; the filing lists the RSUs with a $0 price.

Who signed the Form 4 and when was it filed?

The Form 4 was signed by an attorney-in-fact (/s/ Kortney Q. Nordrum) on 08/22/2025.